Tvardi Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as pipeline advances Anthropic Microsoft in Talks for Custom AI Chip Deal Following 5 Billion Investment Ocugen Q1 2026 Earnings EPS Misses Estimates Amid Continued PreClinical Stage PFLT Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Challenging Rate Environment SLMBP Q1 2026 Earnings Preferred Stock EPS Surges 356 Above Estimates Reflecting Strong Core Performance CVKD Q1 2026 Earnings Narrowing Losses and Steady Progress in Clinical Pipeline Global Markets Rally on Hopes from TrumpXi Summit Strait of Hormuz Commitment Boosts Sentiment